Floatz logo

84 assets in T-Cell Non-Hodgkin Lymphoma

Therapeutic assets addressing T-Cell Non-Hodgkin Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
gw5282
T-Cell Non-Hodgkin Lymphoma
Dizal PharmaceuticalsP1/2CCC (48)
Mitoxantrone
T-Cell Non-Hodgkin Lymphoma
The First Affiliated Hospital with Nanjing Medical UniversityP1/2CCC (48)
Parsaclisib
T-Cell Non-Hodgkin Lymphoma
Walter HanelP1CC (46)
bi-1808
T-Cell Non-Hodgkin Lymphoma
BioInvent International ABP1/2CC (45)
Durvalumab
T-Cell Non-Hodgkin Lymphoma
University of VirginiaP1/2CC (45)
Enzalutamide
T-Cell Non-Hodgkin Lymphoma
Novartis PharmaceuticalsP1/2CC (45)
stp938
T-Cell Non-Hodgkin Lymphoma
Step Pharma, SASP1/2CC (45)
Tulmimetostat
T-Cell Non-Hodgkin Lymphoma
Novartis PharmaceuticalsP1/2CC (45)
prt2527
T-Cell Non-Hodgkin Lymphoma
Prelude TherapeuticsP1CC (44)
Zanubrutinib
T-Cell Non-Hodgkin Lymphoma
Prelude TherapeuticsP1CC (44)
Allogeneic Cd5.Car/28Zeta Car T Cells
T-Cell Non-Hodgkin Lymphoma
Baylor College of MedicineP1CC (43)
Besufetamig
T-Cell Non-Hodgkin Lymphoma
Ono Pharmaceutical Co., Ltd.P1CC (43)
Cart-45 Cells
T-Cell Non-Hodgkin Lymphoma
University of PennsylvaniaP1CC (43)
cd45be-hspc
T-Cell Non-Hodgkin Lymphoma
University of PennsylvaniaP1CC (43)
cd70 car-nk
T-Cell Non-Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityP1CC (43)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
T-Cell Non-Hodgkin Lymphoma
Mayo ClinicP1CC (43)
Lcar-T2C Car-T Cells
T-Cell Non-Hodgkin Lymphoma
The First Affiliated Hospital with Nanjing Medical UniversityP1CC (43)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
T-Cell Non-Hodgkin Lymphoma
Mayo ClinicP1CC (43)
Senza5 Cart5
T-Cell Non-Hodgkin Lymphoma
Vittoria BiotherapeuticsP1CC (43)
Tazemetostat
T-Cell Non-Hodgkin Lymphoma
University of Alabama at BirminghamP1CC (43)
Wu-Cart-007
T-Cell Non-Hodgkin Lymphoma
Washington University School of MedicineP1CC (43)
Abatacept Recombinant
T-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P1CC (41)
cd4car
T-Cell Non-Hodgkin Lymphoma
Huda SalmanP1CC (41)
Fenretinide
T-Cell Non-Hodgkin Lymphoma
SciTech Development, Inc.P1CC (41)
gcc2005
T-Cell Non-Hodgkin Lymphoma
GC Cell CorporationP1CC (41)
lb1901
T-Cell Non-Hodgkin Lymphoma
Legend Biotech USA IncP1CC (41)
Senl101
T-Cell Non-Hodgkin Lymphoma
Hebei Senlang Biotechnology Inc., Ltd.P1CC (41)
Tagraxofusp
T-Cell Non-Hodgkin Lymphoma
Therapeutic Advances in Childhood Leukemia ConsortiumP1CC (41)
CD147-CAR T cells
T-Cell Non-Hodgkin Lymphoma
Peking University People's HospitalEarly P1C (39)
Hneo-T
T-Cell Non-Hodgkin Lymphoma
BGI, ChinaEarly P1C (38)
Cidapenem
T-Cell Non-Hodgkin Lymphoma
The First Affiliated Hospital with Nanjing Medical UniversityN/AD (30)
Bms-986369
T-Cell Non-Hodgkin Lymphoma
Bristol-Myers SquibbP1/2NR ()
kk2223
T-Cell Non-Hodgkin Lymphoma
Kyowa Kirin, Inc.P1NR ()
Showing 51 to 84 of 84 assets
PreviousPage 2 of 2Next